Back

Long-term safety, tolerability, and efficacy of evolocumab in patients with heterozygous familial hypercholesterolaemia

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 2 - Cardiovascular prevention outcomes I Primary cardiovascular prevention: interventions and outcomes ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor G Kees Hovingh

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

19 More presentations in this session

Presentation thumbnail
Nurse-led telephone-based follow-up of secondary prevention after acute myocardial infarction: one-year results from the randomized controlled NAILED-ACS trial.
Doctor D. Huber (Umea, SE)
Abstract Slides
Presentation thumbnail
Six sigma approach to reduce door-to-balloon time for patients with ST-elevation myocardial infarction undergoing primary PCI
Doctor T. Sharma (Baltimore, US)
Abstract Slides
Presentation thumbnail
Evolution of European Society of Cardiology Guidelines since 2000: a systematic appraisal
Doctor C. Badu-Boateng (Reading, GB)
Abstract Slides
Presentation thumbnail
Inhibition of acetylcholinesterase by bromide pyridostigmine prevents ventricular dysfunction, autonomic and reduce inflammatory profile in rats treated previously to myocardial infarction
Ms C. Barboza (Sao Paulo, BR)
Abstract Slides
Presentation thumbnail
Antihypertensive and anti-inflammatory effects of pentoxifylline? A Systematic review and meta-analysis of randomized controlled trials
Doctor D. Brie (Timisoara, RO)
Abstract

Access the full session

Session thumbnail
Poster session 2 - Cardiovascular prevention outcomes I

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources